MX9306310A - Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen - Google Patents
Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienenInfo
- Publication number
- MX9306310A MX9306310A MX9306310A MX9306310A MX9306310A MX 9306310 A MX9306310 A MX 9306310A MX 9306310 A MX9306310 A MX 9306310A MX 9306310 A MX9306310 A MX 9306310A MX 9306310 A MX9306310 A MX 9306310A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- hydrogen
- formula
- receptor
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
La presente invención se relaciona con los compuestos de fórmula (I), y las sales farmacéuticamente aceptables de los mismos, y el uso de un compuesto de fórmula (I) o una sal farmacéuticamente aceptable del mismo: en donde R1 es hidrógeno o alquilo de C1-6; R2 es hidrógeno o halo; Y es 0 o NH; Z es subfórmula (i). (ii), (iii), (iv) o (v): o en donde el anillo de piperidina (i) o (ii) es reemplazado por pirrolidinilo y/o el N-sustituyente en (i) o (ii) es reemplazado por R3 en donde R3 es hidrógeno o alquilo C1-12, aralquilo o R3 es (CH2)r-R10 en donde r es 2 ó 3 y R10 es seleccionado de ciano, hidroxilo, alcoxi de C1-6, fenoxi, C(O)alquilo de C1-6, COC6H5,-CONR11R12, NR11COR12, SO2NR11R12 o NR11SO2R12 en donde R11 y R12 son hidrógeno o alquilo de C1-6; o un compuesto de fórmula (I) en donde el enlace CO-Y es reemplazado por un bioisóstero heterocíclico; que tiene actividad antagonista de receptor de 5-HT4.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929221468A GB9221468D0 (en) | 1992-10-13 | 1992-10-13 | Pharmaceuticals |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9306310A true MX9306310A (es) | 1994-04-29 |
Family
ID=10723359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9306310A MX9306310A (es) | 1992-10-13 | 1993-10-11 | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0664808A1 (es) |
JP (1) | JPH08502274A (es) |
CN (1) | CN1092775A (es) |
AU (1) | AU5177093A (es) |
CA (1) | CA2146928A1 (es) |
GB (1) | GB9221468D0 (es) |
MX (1) | MX9306310A (es) |
WO (1) | WO1994008998A1 (es) |
ZA (1) | ZA937505B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5998409A (en) * | 1992-03-12 | 1999-12-07 | Smithkline Beecham Plc | Condensed indole derivatives as 5HT4 -receptor antagonists |
US5852014A (en) * | 1992-03-12 | 1998-12-22 | Smithkline Beecham P.L.C. | Condensed indole derivatives as 5HT4 -receptor antagonists |
US5726187A (en) * | 1992-10-16 | 1998-03-10 | Smithkline Beecham Plc | N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists |
KR100469029B1 (ko) * | 1996-02-15 | 2005-05-27 | 얀센 파마슈티카 엔.브이. | 세로토닌재흡수억제제의위장효과를극복하기위한5ht4수용체길항제의용도 |
FR2797630B1 (fr) * | 1999-08-20 | 2005-04-29 | Univ Caen Basse Normandie | DERIVES ETHERS DE PYRROLO[1,2-a] QUINOXALINES, LEUR PROCEDE DE PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
US6624162B2 (en) | 2001-10-22 | 2003-09-23 | Pfizer Inc. | Imidazopyridine compounds as 5-HT4 receptor modulators |
CA2461159A1 (en) * | 2001-10-22 | 2003-05-01 | Pfizer Inc. | Imidazopyridine compounds as 5-ht4 receptor modulators |
MXPA03000145A (es) | 2002-01-07 | 2003-07-15 | Pfizer | Compuestos de oxo u oxi-piridina como moduladores de receptores 5-ht4. |
GB0211230D0 (en) | 2002-05-16 | 2002-06-26 | Medinnova Sf | Treatment of heart failure |
WO2004026868A1 (en) | 2002-09-20 | 2004-04-01 | Pfizer Japan Inc. | N-substituted piperidinyl-imidazopyridine compounds as 5-ht4 receptor modulators |
DOP2003000703A (es) | 2002-09-20 | 2004-03-31 | Pfizer | Compuestos de imidazopiradina como agonistas del receptor 5-ht4 |
BRPI0409592A (pt) * | 2003-04-21 | 2006-05-02 | Pfizer | compostos imidazopiridina tendo atividade agonìstica do receptor 5-ht4 e atividade antagonìstica do receptor 5-ht3 |
GEP20094638B (en) | 2004-06-15 | 2009-03-10 | Pfizer | Benzimidazolone carboxylic acid derivatives |
US7737163B2 (en) | 2004-06-15 | 2010-06-15 | Pfizer Inc. | Benzimidazolone carboxylic acid derivatives |
CN104761551A (zh) * | 2015-03-31 | 2015-07-08 | 山东友帮生化科技有限公司 | 6-碘-8-羧基咪唑并(1,2-a)吡啶的合成方法 |
CN104725376A (zh) * | 2015-03-31 | 2015-06-24 | 山东友帮生化科技有限公司 | 6-氯-8-羧基咪唑并[1,2-a]吡啶的合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9103862D0 (en) * | 1991-02-25 | 1991-04-10 | Glaxo Group Ltd | Chemical compounds |
US5260303A (en) * | 1991-03-07 | 1993-11-09 | G. D. Searle & Co. | Imidazopyridines as serotonergic 5-HT3 antagonists |
-
1992
- 1992-10-13 GB GB929221468A patent/GB9221468D0/en active Pending
-
1993
- 1993-10-11 MX MX9306310A patent/MX9306310A/es unknown
- 1993-10-11 ZA ZA937505A patent/ZA937505B/xx unknown
- 1993-10-12 WO PCT/EP1993/002808 patent/WO1994008998A1/en not_active Application Discontinuation
- 1993-10-12 EP EP93922942A patent/EP0664808A1/en not_active Withdrawn
- 1993-10-12 JP JP6509615A patent/JPH08502274A/ja active Pending
- 1993-10-12 CN CN93114853A patent/CN1092775A/zh active Pending
- 1993-10-12 CA CA002146928A patent/CA2146928A1/en not_active Abandoned
- 1993-10-12 AU AU51770/93A patent/AU5177093A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1092775A (zh) | 1994-09-28 |
WO1994008998A1 (en) | 1994-04-28 |
GB9221468D0 (en) | 1992-11-25 |
JPH08502274A (ja) | 1996-03-12 |
AU5177093A (en) | 1994-05-09 |
EP0664808A1 (en) | 1995-08-02 |
CA2146928A1 (en) | 1994-04-28 |
ZA937505B (en) | 1994-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9306310A (es) | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
AR033306A1 (es) | Compuestos | |
DK0783490T3 (da) | 1-Acyl-4-alifatiske aminopiperidinforbindelser | |
MX9305379A (es) | Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene. | |
DK0794949T3 (da) | Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler | |
FI842691A0 (fi) | Derivat av 2-azabicyklo/3,1,0/hexan-3- karbonsyra, foerfarande foer framstaellning, dessa innehaollande medel och deras anvaendning samt 2-azabicyklo/3,1,0/hexanderivat som mellanprodukter och foerfarande foer deras framstaellning. | |
FI954105A (fi) | Uusia 4-aminopyridiinejä, niiden valmistusmenetelmä sekä näitä yhdisteitä sisältäviä lääkkeitä | |
MX9803407A (es) | Derivados de piperazina 1-(1,2-disustituido piperidinil)-4-sustituidos. | |
FI970317A0 (fi) | Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä | |
ATE235476T1 (de) | Thiazolidindione derivate, ihre herstellung und verwendung | |
BG104287A (en) | Halogensubstituted tetracyclic derivatives of tetrahydrofuran | |
NZ213840A (en) | Dichloroaniline derivatives and pharmaceuticals | |
EA199800602A1 (ru) | N-ацил-2-замещенный-4-(бензимидазолил- или имидазопиридинил -замещенные остатки)-пиперидины как антагонисты тахикинина | |
AR003137A1 (es) | Una composicion farmaceutica para tratar la leucemia | |
AR018632A1 (es) | Compuestos derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico, su uso en la fabricacion de medicamentos, composicion farmaceutica que los contiene, proceso para su preparacion. | |
HUP0103020A2 (hu) | Heterociklusos származékok mint FKBP inhibitorok, eljárás az előállításukra, köztitermékeik és ezeket tartalmazó gyógyszerkészítmények | |
AR027454A1 (es) | Derivados de beta-alanina, utiles como antagonistas de receptores, las composiciones farmaceuticas que las contienen y el uso de los mismos para lapreparacion de medicamentos | |
DE69221634T2 (de) | 5-Piperazinylalkyl)-1,5-Benzothiazepinone verwendbar als Calciumantagonisten | |
ES2016017A6 (es) | Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico. | |
AR027035A1 (es) | Pirroles sustituidos | |
AR012249A1 (es) | Compuestos de amonio cuaternario, procedimiento para su preparacion, composicion farmaceutica que los contiene, y su uso para la preparacion de medicamentos | |
MX9305918A (es) | Derivados de n-(2-amino-2-oxoetil)butanodiamida inhibidores de la renina procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
TW333525B (en) | New perhydroisoindole derivatives, their preparation and the pharmaceutical compositions which contain them the invention relates to perhydroisoindole derivatives of general formula (I), and their salts when they exist advantageously as neurokinin A antagonists. | |
AU3626189A (en) | New derivatives of phenothiazine, their preparation and the compositions which contain them | |
DE69532187D1 (de) | Abeo-ergolinderivate als 5ht1a liganden |